Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-007871·Helus Pharma Inc.
Schedule 13G ownership disclosure
CYBIN INC
Common Stock, no par value · CUSIP: 23256X407
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 1,830,097.00 · Class: 9.1%
- KEVIN TANG
Shares: 1,830,097.00 · Class: 9.1%
- TANG CAPITAL PARTNERS, LP
Shares: 1,248,047.00 · Class: 6.2%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 582,050.00 · Class: 2.9%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-007871
- Form type
- SCHEDULE 13G/A
- Filer
- Helus Pharma Inc.
- CIK
- CIK 1833141
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership